Back to Previous Page

Anti-Amyloid-beta (oligomer) Antibody, clone F11G3 clone F11G3, from mouse

ITEM#: 3042-MABN1839

MFR#: MABN1839

Accumulations of insoluble deposits/aggregates are the hallmarks of several neurodegenerative diseases. Deposits involving Abeta and tau proteins in Alzheimer's disease (AD), alpha-synuclein (alpha-syn) in Parkinson's disease (PD), prion protein (PrP

See More Details
Accumulations of insoluble deposits/aggregates are the hallmarks of several neurodegenerative diseases. Deposits involving Abeta and tau proteins in Alzheimer's disease (AD), alpha-synuclein (alpha-syn) in Parkinson's disease (PD), prion protein (PrP) in prion diseases (PrD), TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia-TDP (FTLD-TDP) are well known examples. Evidence suggests that oligomers represent the more toxic species than fibrillar deposits in neurodegenerative conditions, such as AD, PD, and PrD. The number of Abeta deposits, for example, correlates poorly with disease progression, and many researchers consider them to be inert or even protective. Antibodies targeting beta-sheet oligomer conformations are being developed not only to study neurotoxic oligomers, but also for diagnostic and therapeutic purposes.
Provide Content Correction
Product Name Description Item# QTY
Anti-Amyloid Beta 3NTyr10 Antibody, clone 4A5E8 clone 4A5E8, from mouse Deposition of Amyloid beta (Ab) is an early event in the pathogenesis of Alzheimer s disease (AD). Ab peptides originate from the proteolytic cleavage of the amyloid precursor protein (APP). The beta-secretase cleaves APP between residues Met671 and 3042-MABN779 EA
Anti-phospho-Amyloid beta (Ser8) Antibody, clone 1E4E11 clone 1E4E11, from mouse Amyloid beta A4 protein (UniProt P05067; also known as ABPP, Alzheimer disease amyloid protein, Amyloid precursor protein, APP, APPI, Cerebral vascular amyloid peptide, CVAP, PN-II, PreA4, Protease nexin-II) is encoded by the APP (also known as A4, A 3042-MABN878 EA
Anti-Amyloid beta Antibody, clone W0-2 clone WO2, from mouse The cerebral and vascular plaques associated with Alzheimer's disease (AD) are mainly composed of amyloid beta peptides (Abeta). Abeta is derived from cleavage of the amyloid precursor protein (APP) and varies in length from 39 to 43 amino acids. Abe 3042-MABN10 EA
Anti-Amyloid beta42 Antibody, clone G2-11 clone G2-11, from mouse The cerebral and vascular plaques associated with Alzheimer's disease (AD) are mainly composed of amyloid beta peptides (Abeta). Abeta is derived from cleavage of the amyloid precursor protein (APP) and varies in length from 39 to 43 amino acids. Abe 3042-MABN12 EA
Anti-Amyloid beta42 Antibody, clone G2-13 clone G2-13, from mouse The cerebral and vascular plaques associated with Alzheimer's disease (AD) are mainly composed of amyloid beta peptides (Abeta). Abeta is derived from cleavage of the amyloid precursor protein (APP) and varies in length from 39 to 43 amino acids. Abe 3042-MABN13 EA
Thank you for visiting. We look forward to serving you!

Read more about us:  Franklin Young Value



For Government, Military, Education and Government Prime Access:


New Customers Existing Customers

Please contact Customer Service with your questions.

Thank you for visiting, your account is pending approval.

You will received email notification for approval within 24hrs.

Contact customerservice@franklinyoung.com for any questions.

Thank you for requesting an account with Franklin Young.

Your request has been declined

We restrict website access to government entities, and related customers.

Please contact customerservice@franklinyoung.com with any questions.